Home » Newsletters » BioWorld Science

BioWorld Science

April 29, 2015

View Archived Issues

Roche reflects on key accomplishments of first quarter 2015

Double-armed oncolytic adenovirus LOAd-703 controls tumor progression

Novel thiazole-valine peptide selectively reverses ABCB1-mediated MDR

Novel c-Myc transgenic mice have potential as model for human cancer

Stealth BioTherapeutics to develop Ocuvia for inherited mitochondrial optic neuropathies

NEOMED collaborates with McGill University on PARG inhibitors for cancer

Liposomal agent CAL-02 neutralizes bacterial toxins

CC-1807: a synthetic host defense protein mimetic for Gram-negative infections

Recombinant human histidyl-tRNA synthetase named FDA orphan drug

Critical Outcome Technologies files IND for COTI-2 in gynecological cancers

BioMarin completes rolling NDA for drisapersen in Duchenne muscular dystrophy

FDA grants fast track designation to GZ/SAR-402671 for Fabry's disease

Phase III data for CAZ-104 presented at ECCMID

Galapagos's filgotinib meets primary endpoint in phase II trial in rheumatoid arthritis

Ofatumumab plus fludarabine and cyclophosphamide meets endpoint in phase III trial in CLL

Clinical development of the nucleoside NS5B inhibitor MIV-802 for HCV infection

Shenzhen Hepalink Pharmaceutical to license Chinese rights to Resverlogix's RVX-208

FDA grants orphan drug designation to Bio-Path's Liposomal Grb-2

Kadmon discloses ROCK 2 inhibitors

Millenium Pharmaceuticals patents ABCG2 inhibitors

Merck & Co. introduces FFAR1 agonists

Glenmark patents ROR-gamma modulators

Istituto Italiano di Tecnologia reports development of Rev-erb inhibitors

FDA gives Brilinta priority review for prevention of post-MI cardiovascular events

Fast track designation for Cerulean's camptothecin nanoparticles for mRCC

PTC Therapeutics advances BMI-1 program into the clinic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...